Calamos Advisors’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Calamos Advisors’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-375,000	Closed	-$3.84M	–	1187
2023 Q1	$3.84M	Hold	375,000	–	–	0.02%	676
2022 Q4	$3.78M	Hold	375,000	–	–	0.02%	717
2022 Q3	$3.7M	Buy	+375,000	New	+$3.68M	0.02%	770

Calamos Advisors's ORIA Position: Q2 2023 in Review

Calamos Advisors sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 375,000 shares — an estimated $3.84M sold.

Calamos Advisors first reported a position in ORIA in Q3 2022 and held it in 3 quarters. The position peaked at $3.84M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Calamos Advisors reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Calamos Advisors sold 375,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $3.84M.
Calamos Advisors first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2022 and held it in 3 quarters.
Calamos Advisors's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $3.84M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Calamos Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.